The Cancer Letter
Newspaper PublishingDistrict of Columbia, United States11-50 Employees
The Cancer Letter is an independent weekly newspaper based in Washington, DC, focusing on oncology and related policy, regulation, and funding issues since 1973. It provides in-depth coverage of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health, with emphasis on institutions such as the National Cancer Institute, NIH, FDA, Congress, cancer centers, and the pharmaceutical industry. Its readership includes leaders at academic centers, community oncology practices, government agencies, professional associations, health IT and industry players, investors, and advocacy groups, reflecting its role as a key source of information for stakeholders shaping oncology and related policy. The publication is recognized for investigative reporting and has received coverage and influence across major outlets and institutions; its reporting has spurred inquiries and actions by government and regulatory bodies. The Cancer Letter is part of the broader newspaper publishing sector and operates in the Washington, DC area, with recent activity highlighting recognition in the Webby Awards related to its podcast and ongoing projects such as the Cancer History Project.
1-888-653-2347 
support@leadiq.com 
